Red Blood Cells: A Newly Described Partner in Central Retinal Vein Occlusion Pathophysiology?

5Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Central retinal vein occlusion (CRVO) is a frequent retinal disorder inducing blindness due to the occlusion of the central vein of the retina. The primary cause of the occlusion remains to be identified leading to the lack of treatment. To date, current treatments mainly target the complications of the disease and do not target the primary dysfunctions. CRVO pathophysiology seems to be a multifactorial disorder; several studies did attempt to decipher the cellular and molecular mechanisms underlying the vessel obstruction, but no consensual mechanism has been found. The aim of the current review is to give an overview of CRVO pathophysiology and more precisely the role of the erythroid lineage. The review presents emerging data on red blood cell (RBC) functions besides their role as an oxygen transporter and how disturbance of RBC function could impact the whole vascular system. We also aim to gather new evidence of RBC involvement in CRVO occurrence.

Cite

CITATION STYLE

APA

Laurance, S., Marin, M., & Colin, Y. (2023, January 1). Red Blood Cells: A Newly Described Partner in Central Retinal Vein Occlusion Pathophysiology? International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms24021072

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free